Because ABCG2 is the primary membrane transporter responsible for drug resistance in breast cancer, our findings implied that the chemosensitizing effects of ISL might be closely correlated with ABCG2 reduction via the autophagy pathway. This evidence concerns the gene ABCG2 and breast carcinoma.